[Immunoscintigraphy with 111-indium-labelled antimyosin antibodies in the assessment of muscle metastases. A case report].
Ferraironi
A
A
Servizio di Medicina Nucleare, Istituto Nazionale Tumori Regina Elena, Roma.
Tofani
A
A
Sciuto
R
R
Cucchi
R
R
Crecco
M
M
Maini
C L
CL
D018263:Adenocarcinoma, Follicular / Q000000981:diagnostic imaging / Q000473:pathology; D000911:Antibodies, Monoclonal; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D006801:Humans; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000000981:diagnostic imaging*; D009218:Myosins / Q000276:immunology*; D009942:Organometallic Compounds; D016719:Radioimmunodetection / Q000379:methods*; D012983:Soft Tissue Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D013669:Technetium Tc 99m Medronate; D013794:Thallium Radioisotopes; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D014915:Whole-Body Counting / Q000379:methods
D000911:Antibodies, Monoclonal; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D009942:Organometallic Compounds; D013794:Thallium Radioisotopes; C058899:imciromab pentetate; D009218:Myosins; D013669:Technetium Tc 99m Medronate
Immunoscintigrafia con anticorpi anti-miosina marcati con 111-indio nella valutazione di metastasi muscolari. Descrizione di un caso.